• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Paltown

Paltown

  • About Us ▼
    • About Us
    • Board of Directors
    • Staff
    • Community Leaders
    • Our Inspiration
    • Financials & Annual Report
    • Partners and Sponsors
  • Communities ▼
    • Communities
    • COLONTOWN University
  • Training ▼
    • Training
    • Clinical Trials Training
    • Empowered Patient Leaders
  • In the News ▼
    • In the News
      • News Archive
    • Press Releases
    • Blog
  • Donate

Chris Heery, MD

September 30, 2018

Dr. Christopher Heery is the Chief Medical Officer for Bavarian Nordic where he oversees the clinical development of BN’s pipeline, comprising therapeutic cancer vaccines and vaccines for prevention of infectious diseases. He is a medical oncologist by training. He trained at the National Cancer Institute in the Laboratory of Tumor Immunology and Biology, where he went on to be the Head of the Clinical Trials group in that translational ImmunoOncology-focused branch. He has personally run a wide variety of immunotherapy trials using a variety of first-in-human agents including therapeutic cancer vaccines, checkpoint inhibitors, antibody-cytokine conjugates, and cytokine targeting antibodies. His trial experience also includes combination strategies in IO and IO with standard therapies based on mechanistic rationale.

Related

Connect with Us

Visit our Communities

The PALTOWN Development Foundation is a 501(c)3 corporation. EIN: 81-4532089

Donate today!

Footer

PALTOWN Development Foundation
969 Diggs Rd., Crownsville, MD, 21032
EIN: 81-4532089
410.881.3160
contact(at)paltown.org

Our policies:

Privacy Policy

Terms of Use Policy

Copyright © 2023 · PALTOWN